Hypertension Clinical Trial
Official title:
A Pilot Study to Improve Patient-Doctor Communication
Verified date | May 2012 |
Source | Walter Reed National Military Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this controlled pilot study is to determine whether an intervention aimed at
patients will improve partnering, shared decision-making and open communication. Results from
this pilot study will inform how to best proceed with a larger multi-centered randomized
controlled trial.
The specific hypothesis for this pilot study is to:
1. Test the feasibility of a simple patient-centered intervention.
2. Test the correlation between patient readiness to actively engage in conversation
(assessed using a pre-visit patient survey) and actual patient behaviors in the
encounter.
3. Develop a coding tool that will quantify patient activation in clinical encounters.
4. Test whether activating patients who are more involved and revealing in the
patient-clinician dyad will improve patient and clinician outcomes.
Status | Completed |
Enrollment | 106 |
Est. completion date | November 2011 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Military health care beneficiaries presenting for chronic medical care with their primary care clinician - Over the age of 18 - At least 2 and no more than 10 visits with their primary care provider in the previous year - Receiving pharmacological treatment for hypertension - At least 2 of the following common chronic illnesses: hyperlipidemia, chronic obstructive pulmonary disease, asthma, congestive heart failure, chronic pain, ischemic heart disease, osteoarthritis, depression, back pain, chronic headaches, or diabetes Exclusion Criteria: - Over the age of 80 - Incapable of completing the questionnaires, either due to cognitive impairment or lack of English-literacy |
Country | Name | City | State |
---|---|---|---|
United States | Walter Reed National Medical Military Center (WRNMMC) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
Walter Reed National Military Medical Center | University of Wisconsin, Milwaukee |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Degree of shared medical decision-making | Assessed from transcribed audio-tapes of the doctor-patient encounter using Roter Interaction Analysis System (RIAS). | Baseline | |
Primary | Adherence to anti-hypertensive drug treatment at baseline | This outcome will be assessed using pill counts by the pharmacists. | Baseline | |
Primary | Adherence to anti-hypertensive drug treatment at one month | This outcome will be assessed using pill counts by the pharmacists. | One month | |
Primary | Adherence to anti-hypertensive drug treatment at three months | This outcome will be assessed using pill counts by the pharmacists. | Three months | |
Secondary | Patient satisfaction | Post-encounter survey using the validated Rand-9 Patient Satisfaction Tool | Baseline | |
Secondary | Clinician rating of patient as "difficult" | Clinician Rating of the Encounter Using the Difficult Doctor-Patient Relationship Questionaire (DDPRQ). | Baseline | |
Secondary | Patient Trust in their physician at baseline | Validated Trust in Physician (11-item) Instrument | Baseline | |
Secondary | Patient Trust in their physician at one month | Validated Trust in Physician (11-item) Instrument | one month | |
Secondary | Patient Trust in their physician at three months | Validated Trust in Physician (11-item) Instrument | Three months | |
Secondary | Systolic and Diastolic Blood Pressure at baseline | Each blood pressure data point was the average of 3 measurements measured 5 minutes apart while seated. | Baseline | |
Secondary | Systolic and Diastolic Blood Pressure at one month | Each blood pressure data point was the average of 3 measurements measured 5 minutes apart while seated. | One month | |
Secondary | Systolic and Diastolic Blood Pressure at three months | Each blood pressure data point was the average of 3 measurements measured 5 minutes apart while seated. | three months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |